Jeong H. Heo
Busan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 137 publications
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection.
Journal: The New England journal of medicine
Published: May 28, 2026
Durvalumab and tremelimumab, with or without lenvatinib, combined with transarterial chemoembolisation in participants with embolisation-eligible hepatocellular carcinoma (EMERALD-3): a global, randomised, open-label, sponsor-blinded, phase 3 study.
Journal: The Lancet. Oncology
Published: May 08, 2026
A phase Ib/2a study of fostrox in combination with lenvatinib as second line therapy in patients with advanced hepatocellular carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 23, 2026
A Phase Ib/IIa Study of Fostrox in Combination with Lenvatinib as Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 23, 2026
Therapeutic Strategies for Hepatocellular Carcinoma: Current Advances and Future Perspectives.
Journal: Vaccines
Published: January 08, 2026
Engineering Multi-Functional Enzyme-Mimetic Polyphenol-Catalase Complex for Reversing Hypoxia and Redox Homeostasis in Vascular and Muscular Regeneration.
Journal: ACS nano
Published: December 17, 2025
Observational, Post-marketing Surveillance of Safety and Effectiveness of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C.
Journal: Infectious diseases and therapy
Published: December 11, 2025
Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies.
Journal: Hepatology communications
Published: October 24, 2025
Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study).
Journal: Infectious diseases and therapy
Published: February 26, 2025
Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C.
Journal: Journal of gastroenterology and hepatology
Published: December 17, 2024
Reply to: "Sequential therapy with antisense oligonucleotide and immune modulator as a strategy for HBV cure".
Journal: Journal of hepatology
Published: December 03, 2024
Last Updated: 09/26/2026